Share Twitter LinkedIn Facebook Email Timothy Yap, MBBS, Ph.D., MD Anderson Cancer Center, talks about Abnormalities With Next-Gen Sequencing Widen therapeutic options by tailoring trials to aberrations at AACR 2018.